drugset / Trial / NCT00308295

A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients

NCT00308295

Completed 27 enrolled Indiana University
RandomizedParallel-groupDouble-blindTreatment

Summary

The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.

Timeline

Start
2006-04
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fish oil Other / unclassified